These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 27222525)

  • 1. Insulin Resistance Intervention After Stroke Trial of Pioglitazone: Is This Perhaps the End of the Beginning?
    Ntaios G; Kent TA
    Stroke; 2016 Jul; 47(7):1962-4. PubMed ID: 27222525
    [No Abstract]   [Full Text] [Related]  

  • 2. Pioglitazone and cardiovascular outcomes in patients with insulin resistance, pre-diabetes and type 2 diabetes: a systematic review and meta-analysis.
    Liao HW; Saver JL; Wu YL; Chen TH; Lee M; Ovbiagele B
    BMJ Open; 2017 Jan; 7(1):e013927. PubMed ID: 28057658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rosiglitazone and pioglitazone in the treatment of diabetes mellitus.
    Odom J; Williamson B; Carter L
    Am J Health Syst Pharm; 2008 Oct; 65(19):1846-50. PubMed ID: 18796427
    [No Abstract]   [Full Text] [Related]  

  • 4. Peroxisome proliferator-activated receptor-γ (PPAR-γ) agonists on glycemic control, lipid profile and cardiovascular risk.
    Derosa G; Maffioli P
    Curr Mol Pharmacol; 2012 Jun; 5(2):272-81. PubMed ID: 22122457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do thiazolidinediones still have a role in treatment of type 2 diabetes mellitus?
    Consoli A; Formoso G
    Diabetes Obes Metab; 2013 Nov; 15(11):967-77. PubMed ID: 23522285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-Term Pioglitazone Treatment for Patients With Nonalcoholic Steatohepatitis and Prediabetes or Type 2 Diabetes Mellitus: A Randomized Trial.
    Cusi K; Orsak B; Bril F; Lomonaco R; Hecht J; Ortiz-Lopez C; Tio F; Hardies J; Darland C; Musi N; Webb A; Portillo-Sanchez P
    Ann Intern Med; 2016 Sep; 165(5):305-15. PubMed ID: 27322798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of pioglitazone on bone in postmenopausal women with impaired fasting glucose or impaired glucose tolerance: a randomized, double-blind, placebo-controlled study.
    Bone HG; Lindsay R; McClung MR; Perez AT; Raanan MG; Spanheimer RG
    J Clin Endocrinol Metab; 2013 Dec; 98(12):4691-701. PubMed ID: 24057294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Determining the current position regarding the value of pioglitazone for the therapy of diabetes].
    Eckert S; Erdmann E; Lundershausen R; Forst T; Scherbaum WA; Schnell O; Standl E; Schumm-Draeger PM; Tschöpe D; Walter H; Weber M
    Dtsch Med Wochenschr; 2007 Dec; 132(49):2650-3. PubMed ID: 18050033
    [No Abstract]   [Full Text] [Related]  

  • 9. Pioglitazone Therapy in Patients With Stroke and Prediabetes: A Post Hoc Analysis of the IRIS Randomized Clinical Trial.
    Spence JD; Viscoli CM; Inzucchi SE; Dearborn-Tomazos J; Ford GA; Gorman M; Furie KL; Lovejoy AM; Young LH; Kernan WN;
    JAMA Neurol; 2019 May; 76(5):526-535. PubMed ID: 30734043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pioglitazone after Ischemic Stroke or Transient Ischemic Attack.
    Kernan WN; Viscoli CM; Furie KL; Young LH; Inzucchi SE; Gorman M; Guarino PD; Lovejoy AM; Peduzzi PN; Conwit R; Brass LM; Schwartz GG; Adams HP; Berger L; Carolei A; Clark W; Coull B; Ford GA; Kleindorfer D; O'Leary JR; Parsons MW; Ringleb P; Sen S; Spence JD; Tanne D; Wang D; Winder TR;
    N Engl J Med; 2016 Apr; 374(14):1321-31. PubMed ID: 26886418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exercise training augments the peripheral insulin-sensitizing effects of pioglitazone in HIV-infected adults with insulin resistance and central adiposity.
    Yarasheski KE; Cade WT; Overton ET; Mondy KE; Hubert S; Laciny E; Bopp C; Lassa-Claxton S; Reeds DN
    Am J Physiol Endocrinol Metab; 2011 Jan; 300(1):E243-51. PubMed ID: 20959530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluid compartmental shifts with efficacious pioglitazone therapy in overweight monkeys: implications for peroxisome proliferator-activated receptor-gamma agonist use in prediabetes.
    Kavanagh K; Brown KK; Berquist ML; Zhang L; Wagner JD
    Metabolism; 2010 Jun; 59(6):914-20. PubMed ID: 20197197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac Outcomes After Ischemic Stroke or Transient Ischemic Attack: Effects of Pioglitazone in Patients With Insulin Resistance Without Diabetes Mellitus.
    Young LH; Viscoli CM; Curtis JP; Inzucchi SE; Schwartz GG; Lovejoy AM; Furie KL; Gorman MJ; Conwit R; Abbott JD; Jacoby DL; Kolansky DM; Pfau SE; Ling FS; Kernan WN;
    Circulation; 2017 May; 135(20):1882-1893. PubMed ID: 28246237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of pioglitazone, one of TZDs, on IGT-patients].
    Kobayashi M
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():462-70. PubMed ID: 15779423
    [No Abstract]   [Full Text] [Related]  

  • 15. Association between congestive heart failure and hospitalization in patients with type 2 diabetes mellitus receiving treatment with insulin or pioglitazone: a retrospective data analysis.
    Rajagopalan R; Rosenson RS; Fernandes AW; Khan M; Murray FT
    Clin Ther; 2004 Sep; 26(9):1400-10. PubMed ID: 15531002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial.
    Dormandy JA; Charbonnel B; Eckland DJ; Erdmann E; Massi-Benedetti M; Moules IK; Skene AM; Tan MH; Lefèbvre PJ; Murray GD; Standl E; Wilcox RG; Wilhelmsen L; Betteridge J; Birkeland K; Golay A; Heine RJ; Korányi L; Laakso M; Mokán M; Norkus A; Pirags V; Podar T; Scheen A; Scherbaum W; Schernthaner G; Schmitz O; Skrha J; Smith U; Taton J;
    Lancet; 2005 Oct; 366(9493):1279-89. PubMed ID: 16214598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pioglitazone: Hype and hope.
    Jadhav SS; Shivane VK; Lila AR; Bandgar TR; Shah NS
    J Postgrad Med; 2014; 60(3):293-6. PubMed ID: 25121371
    [No Abstract]   [Full Text] [Related]  

  • 18. Pioglitazone for Patients With Nonalcoholic Steatohepatitis and Prediabetes or Type 2 Diabetes.
    Ann Intern Med; 2016 Sep; 165(5):. PubMed ID: 27322943
    [No Abstract]   [Full Text] [Related]  

  • 19. Pioglitazone: more than just an insulin sensitizer.
    Czaja MJ
    Hepatology; 2009 May; 49(5):1427-30. PubMed ID: 19402055
    [No Abstract]   [Full Text] [Related]  

  • 20. Heart Failure After Ischemic Stroke or Transient Ischemic Attack in Insulin-Resistant Patients Without Diabetes Mellitus Treated With Pioglitazone.
    Young LH; Viscoli CM; Schwartz GG; Inzucchi SE; Curtis JP; Gorman MJ; Furie KL; Conwit R; Spatz ES; Lovejoy A; Abbott JD; Jacoby DL; Kolansky DM; Ling FS; Pfau SE; Kernan WN;
    Circulation; 2018 Sep; 138(12):1210-1220. PubMed ID: 29934374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.